Eli Lilly shares are trading higher after CVS announced that it will reintroduce the company's Zepbound treatment as a covered medication from October 1.

Benzinga Newsdesk www.benzinga.com Positive 94.4%

Neg 0% Neu 0% Pos 94.4%

Comments

No comments yet. Be the first!